These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25269476)

  • 1. MiR200-upregulated Vasohibin 2 promotes the malignant transformation of tumors by inducing epithelial-mesenchymal transition in hepatocellular carcinoma.
    Xue X; Zhang Y; Zhi Q; Tu M; Xu Y; Sun J; Wei J; Lu Z; Miao Y; Gao W
    Cell Commun Signal; 2014 Oct; 12():62. PubMed ID: 25269476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasohibin 2 is transcriptionally activated and promotes angiogenesis in hepatocellular carcinoma.
    Xue X; Gao W; Sun B; Xu Y; Han B; Wang F; Zhang Y; Sun J; Wei J; Lu Z; Zhu Y; Sato Y; Sekido Y; Miao Y; Kondo Y
    Oncogene; 2013 Mar; 32(13):1724-34. PubMed ID: 22614011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasohibin 2 promotes malignant behaviors of pancreatic cancer cells by inducing epithelial-mesenchymal transition via Hedgehog signaling pathway.
    Zhang Y; Xue X; Zhao X; Qin L; Shen Y; Dou H; Sun J; Wang T; Yang DQ
    Cancer Med; 2018 Nov; 7(11):5567-5576. PubMed ID: 30318866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasohibin 2 decreases the cisplatin sensitivity of hepatocarcinoma cell line by downregulating p53.
    Li Z; Tu M; Han B; Gu Y; Xue X; Sun J; Ge Q; Miao Y; Qian Z; Gao W
    PLoS One; 2014; 9(3):e90358. PubMed ID: 24595063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vasohibin-2 promotes proliferation and metastasis of cervical cancer cells by regulating epithelial-mesenchymal transition].
    Wang J; Yu C; Jiang X; Wu X; Jia Y; Zhang H; Li Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jul; 42(7):966-975. PubMed ID: 35869758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasohibin 2 promotes epithelial-mesenchymal transition in human breast cancer via activation of transforming growth factor β 1 and hypoxia dependent repression of GATA-binding factor 3.
    Tu M; Li Z; Liu X; Lv N; Xi C; Lu Z; Wei J; Song G; Chen J; Guo F; Jiang K; Wang S; Gao W; Miao Y
    Cancer Lett; 2017 Mar; 388():187-197. PubMed ID: 27867016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1.
    Song LN; Qiao GL; Yu J; Yang CM; Chen Y; Deng ZF; Song LH; Ma LJ; Yan HL
    J Exp Clin Cancer Res; 2020 Jun; 39(1):114. PubMed ID: 32552766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.
    Qiu G; Lin Y; Zhang H; Wu D
    Biochem Biophys Res Commun; 2015 Jul; 463(3):315-21. PubMed ID: 26022123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of miRNA-30c and miR-203a is associated with hepatitis C virus core protein-induced epithelial-mesenchymal transition in normal hepatocytes and hepatocellular carcinoma cells.
    Liu D; Wu J; Liu M; Yin H; He J; Zhang B
    Biochem Biophys Res Commun; 2015 Sep; 464(4):1215-1221. PubMed ID: 26210453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear vasohibin-2 promotes cell proliferation by inducing G0/G1 to S phase progression.
    Ge Q; Zhou J; Tu M; Xue X; Li Z; Lu Z; Wei J; Song G; Chen J; Guo F; Jiang K; Miao Y; Gao W
    Oncol Rep; 2015 Sep; 34(3):1327-36. PubMed ID: 26177649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. lncRNA TUG1-Mediated Mir-142-3p Downregulation Contributes to Metastasis and the Epithelial-to-Mesenchymal Transition of Hepatocellular Carcinoma by Targeting ZEB1.
    He C; Liu Z; Jin L; Zhang F; Peng X; Xiao Y; Wang X; Lyu Q; Cai X
    Cell Physiol Biochem; 2018; 48(5):1928-1941. PubMed ID: 30092578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasohibin-2 is required for epithelial-mesenchymal transition of ovarian cancer cells by modulating transforming growth factor-β signaling.
    Norita R; Suzuki Y; Furutani Y; Takahashi K; Yoshimatsu Y; Podyma-Inoue KA; Watabe T; Sato Y
    Cancer Sci; 2017 Mar; 108(3):419-426. PubMed ID: 28064471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2.
    Ma DN; Chai ZT; Zhu XD; Zhang N; Zhan DH; Ye BG; Wang CH; Qin CD; Zhao YM; Zhu WP; Cao MQ; Gao DM; Sun HC; Tang ZY
    J Hematol Oncol; 2016 Jan; 9():1. PubMed ID: 26733151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CASC15 promotes epithelial to mesenchymal transition and facilitates malignancy of hepatocellular carcinoma cells by increasing TWIST1 gene expression via miR-33a-5p sponging.
    Li Y; Chen G; Yan Y; Fan Q
    Eur J Pharmacol; 2019 Oct; 860():172589. PubMed ID: 31401158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.
    Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y
    Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway.
    Xu Q; Liu X; Liu Z; Zhou Z; Wang Y; Tu J; Li L; Bao H; Yang L; Tu K
    Mol Cancer; 2017 Jun; 16(1):103. PubMed ID: 28606154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PRRX1 deficiency induces mesenchymal-epithelial transition through PITX2/miR-200-dependent SLUG/CTNNB1 regulation in hepatocellular carcinoma.
    Chen W; Wu J; Shi W; Zhang G; Chen X; Ji A; Wang Z; Wu J; Jiang C
    Cancer Sci; 2021 Jun; 112(6):2158-2172. PubMed ID: 33587761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1.
    He Y; He X
    Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-130b promotes cell aggressiveness by inhibiting peroxisome proliferator-activated receptor gamma in human hepatocellular carcinoma.
    Tu K; Zheng X; Dou C; Li C; Yang W; Yao Y; Liu Q
    Int J Mol Sci; 2014 Nov; 15(11):20486-99. PubMed ID: 25387077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Notch1 promotes vasculogenic mimicry in hepatocellular carcinoma by inducing EMT signaling.
    Jue C; Lin C; Zhisheng Z; Yayun Q; Feng J; Min Z; Haibo W; Youyang S; Hisamitsu T; Shintaro I; Shiyu G; Yanqing L
    Oncotarget; 2017 Jan; 8(2):2501-2513. PubMed ID: 27705934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.